Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Acta Cytol ; 55(2): 193-6, 2011.
Article in English | MEDLINE | ID: mdl-21325806

ABSTRACT

OBJECTIVE: Reported urine cytology accuracy, particular sensitivity, is highly variable. We evaluated the accuracy of urinary cytology for primary bladder cancer using population data linkage to provide valid estimates. STUDY DESIGN: Consecutive cytology tests processed through a major service between January 2000 and December 2004 were linked to a regional population cancer registry (allowing outcome ascertainment). Sensitivity and specificity were calculated using different thresholds, based on standardized reporting categories (C1 = negative, C2 = reactive, C3 = atypical, C4 = suspicious, C5 = malignant, Cx = inadequate). RESULTS: Cancer registry matching of 2,594 tests revealed 130 incident bladder cancers, of which 97 occurred within 12 months of cytology and were included in calculating accuracy. Sensitivity (C3-C5 considered positive) ranged between 40.2 and 42.3%, and specificity was 93.7-94.1%. If C3 results are counted as negative, sensitivity estimates reduced to 24.7-26.0%. The positive predictive value of a C3, C4 or C5 report was 11.7, 39.2, and 66.6%, respectively. High tumor grade was associated with significantly higher sensitivity compared to low and intermediate grades combined (p = 0.02). CONCLUSION: Urine cytology is highly specific but has intermediate sensitivity, indicating that it has a role in adjunct diagnosis, but not in screening for primary bladder cancer. C3 results should be considered 'positive' and further investigated, and all positive results should prompt further intervention.


Subject(s)
Cytodiagnosis/methods , Data Collection/statistics & numerical data , Registries/statistics & numerical data , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/urine , Urine/cytology , Humans , Reproducibility of Results , Sensitivity and Specificity
2.
Ciênc. rural (Online) ; 47(11): e20170170, Nov. 2017. tab, graf
Article in English | LILACS | ID: biblio-1044906

ABSTRACT

ABSTRACT: The objective of this study was to evaluate the economic benefit of coffee cultivation, with a focus on the distinction between conventional and irrigated coffee production systems. For the development of the study, the various productive systems were delineated from the data provided by a sample of producers to generate a matrix of average technical coefficients. The methodology used to estimate the operating cost of production is the one used by the Instituto de Economia Agrícola (IEA). Profitability indicators were also evaluated. Results indicated that the effective operational cost (EOC) incurred in the irrigated production system is higher than that in the conventional system. As regards the cost composition, in the conventional coffee production system, the largest cost incurred is on fertilizers among all inputs, whereas in the irrigated production system, the largest cost incurred is on machinery and equipment that are mainly used in harvesting, for the period 2013-2015. Profitability index of the conventional coffee production system in 2015 was 44.8%, and that of the drip irrigated production system was 49.7%. In 2014, profitability rates were negative for both the conventional (-13.9%) and irrigated coffee production systems (-8.6%). The most preferable choice was found to be the irrigated production system, as it allows reducing the risk of loss in production during prolonged periods of water shortage as well as greater yields due to a larger production of grains.


RESUMO: Este estudo teve como objetivo avaliar o benefício econômico do cultivo de café, comparando os sistemas de café convencional e irrigado. Para o desenvolvimento do estudo, os sistemas produtivos foram delineados a partir de dados informados por uma amostra de produtores, para elaboração de uma matriz de coeficientes técnicos médios. A metodologia utilizada para a estimativa do custo operacional de produção é a do Instituto de Economia Agrícola (IEA) e foram avaliados indicadores de rentabilidade. Os resultados apontam que o custo operacional efetivo (COE) no sistema irrigado é maior do que no sistema convencional. Na composição do custo, no sistema de café convencional os maiores gastos foram com adubos no item insumos e, no sistema irrigado, os maiores dispêndios foram com máquinas e equipamentos principalmente com a colheita, nos anos de 2013, 2014 e 2015. O índice de lucratividade para o café convencional em 2015 foi de 44,8% e para o sistema irrigado por gotejo em 49,7%. No ano de 2014, os índices de lucratividade foram negativos tanto para o sistema de produção de café irrigado (- 8,6%) como para o sistema de café convencional (-13,9%). A melhor opção é o sistema irrigado, pois possibilita diminuir o risco de perda na produção em períodos prolongados de déficits hídricos além de possibilitar o maior rendimento com uma produção maior de grãos.

3.
Breast Cancer Res Treat ; 103(1): 85-91, 2007 May.
Article in English | MEDLINE | ID: mdl-17033920

ABSTRACT

INTRODUCTION: Axillary node fine needle aspiration cytology (FNAC) has the potential to triage women with operable breast cancer to initial nodal surgical procedure. Because of variability in the reported accuracy of this test its role and clinical utility in pre-operative staging remains controversial. METHODS: We retrospectively evaluated the accuracy of ultrasound-guided axillary FNAC in all consecutive clinically T1-2 N0-1 breast cancers that had undergone this test (491 biopsies). We included subjects with clinically or sonographically indeterminate or suspicious nodes. Pathological node status was used as the reference standard (based on axillary dissection or sentinel node biopsy). RESULTS: Sensitivity of node FNAC was 72.6% (67.3-77.9) and specificity was 95.7% (92.5-98.8) for all cases, sensitivity was lower at 64.6% (59.3-70.0) if inadequate cytology was included as a negative result. FNAC sensitivity was highest in women with clinically suspicious nodes [92.5% (88.2-96.7)] and lowest in women with sonographically abnormal and clinically negative nodes [50.0% (41.3-58.7)]. Specificity was high in both groups, 81.2% (54.5-96.0) and 97.2% (94.6-99.9), respectively. The false-negative rate was 15.3% (12.1-18.5), the false-positive rate was 1.4% (0.4-2.5), and the inadequacy rate was 10.8% (8.0-13.5). The likelihood of node FNAC being positive was significantly associated with tumour grade and stage, and the number of nodes involved with metastases. DISCUSSION: Our data show that axillary FNAC has moderate sensitivity (which varies according to selection criteria for the test) and consistently high specificity, is associated with low inadequacy and very few false positives. We estimate that its use would have improved triage to initial nodal procedure in about one quarter of our cases. If one accepts the premise that initial surgical staging of the axilla should be based on all information available through pre-operative diagnosis, then axillary FNAC should be adopted routinely into clinical practice.


Subject(s)
Biopsy, Needle , Breast Neoplasms/pathology , Lymph Node Excision , Lymph Nodes/pathology , Triage , Adult , Aged , Aged, 80 and over , Axilla , Biopsy, Needle/instrumentation , Breast Neoplasms/surgery , Female , Humans , Middle Aged , Neoplasm Staging , Retrospective Studies , Sensitivity and Specificity , Ultrasonography, Mammary
4.
Cancer ; 105(3): 152-7, 2005 Jun 25.
Article in English | MEDLINE | ID: mdl-15861428

ABSTRACT

BACKGROUND: The identification of specific morphologic diagnostic criteria is of paramount importance to optimize the accuracy of fine-needle aspiration cytology (FNAC) and to reduce the rate of false-negative results. In the current study, the authors reviewed a consecutive series of false-negative findings observed in the study center to define the presence and degree of cytologic abnormalities. False-negative cases were randomly mixed with true-negative cases and were reviewed by a panel of expert readers in a blinded fashion. The main objective of the current study was to identify a morphologic pattern that may permit the reduction of false-negative findings while maintaining the specificity of FNAC. METHODS: A blind review of a set of 41 consecutive false-negative and 49 true-negative breast aspiration samples was performed by a panel of 10 expert cytologists who were asked to give a final report and to classify the samples according to classic morphologic parameters. RESULTS: The majority final report sensitivity was 54% (range, 19-61%) and specificity was 73% (range, 65-92%). The average concordance with the majority report, adjusted for chance agreement (kappa statistic), was moderate at 0.54 (range, 0.40-0.65). Enlarged nuclear size, a hyperchromatic nucleus, the absence of naked nuclei, and the absence of apocrine metaplasia were reported more frequently in carcinoma cases, although not to a significant extent. The only variable found to be associated significantly (P = 0.041) with a diagnosis of carcinoma was the presence of microcalcifications, which nevertheless were found to occur in only a minority of carcinoma cases (7 of 41 cases) or controls (2 of 49 controls). Multivariate analysis demonstrated that the presence of microcalcifications (odds ration [OR] of 3.0; 95% confidence interval [95% CI], 1.2-7.4), the absence of naked nuclei (OR of 2.4; 95% CI, 1.3-4.4), and enlargement of the nucleus (OR of 1.9; 95% CI, 1.1-3.4) were all independently associated with false-negative findings. Diagnostic accuracy using a morphology-based score did not appear to improve the results substantially compared with the final report (sensitivity of 0.46 vs. 0.54 [P = 0.508] and a specificity of 0.80 vs. 0.73 [P = 0.218]). CONCLUSIONS: The results of the current study confirm that breast FNAC false-negative results are at least partially the result of underreporting of abnormalities that may be noted at review. Detailed analysis of a single morphologic characteristic was found to be of limited diagnostic value, suggesting that operators do perceive abnormalities but cannot translate these findings into distinct morphologic categories.


Subject(s)
Biopsy, Fine-Needle , Breast Neoplasms/pathology , Breast Diseases/pathology , Cohort Studies , Confidence Intervals , Cytodiagnosis/standards , Cytodiagnosis/trends , Diagnosis, Differential , False Negative Reactions , Female , Humans , Immunohistochemistry , Multivariate Analysis , Neoplasm Staging , Observer Variation , Odds Ratio , ROC Curve , Risk Assessment , Sensitivity and Specificity , Specimen Handling
5.
J Natl Cancer Inst ; 97(5): 347-57, 2005 Mar 02.
Article in English | MEDLINE | ID: mdl-15741571

ABSTRACT

BACKGROUND: Although there is general consensus concerning the efficacy of colorectal cancer screening, there is a lack of agreement about which routine screening strategy should be adopted. We compared the participation and detection rates achievable through different strategies of colorectal cancer screening. METHODS: From November 1999 through June 2001 we conducted a multicenter, randomized trial in Italy among a sample of 55-64 year olds in the general population who had an average risk of colorectal cancer. People with previous colorectal cancer, adenomas, inflammatory bowel disease, a recent (< or =2 years) colorectal endoscopy or fecal occult blood test (FOBT), or two first-degree relatives with colorectal cancer were excluded. Eligible subjects were randomly assigned, within the roster of their general practitioner, to 1) biennial FOBT (delivered by mail), 2) biennial FOBT (delivered by general practitioner or a screening facility), 3) patient's choice of FOBT or "once-only" sigmoidoscopy, 4) "once-only" sigmoidoscopy, or 5) sigmoidoscopy followed by biennial FOBT. An immunologic FOBT was used. Participation and detection rates of the strategies tested were compared using multivariable logistic regression models that adjusted for age, sex, and screening center. All statistical tests were two-sided. RESULTS: Of 28 319 people sampled, 1637 were excluded and 26 682 were randomly assigned to a screening arm. After excluding undelivered letters (n = 427), the participation rates for groups 1, 2, 3, 4, and 5 were 30.1% (682/2266), 28.1% (1654/5893), 27.1% (970/3579), 28.1% (1026/3650), and 28.1% (3049/10 867), respectively. Of the 2858 subjects screened by FOBT, 122 (4.3%) had a positive test result, 10 (3.5 per 1000) had colorectal cancer, and 39 (1.4%) had an advanced adenoma. Among the 4466 subjects screened by sigmoidoscopy, 341 (7.6%) were referred for colonoscopy, 18 (4 per 1000) had colorectal cancer, and 229 (5.1%) harbored an advanced adenoma. CONCLUSIONS: The participation rates were similar for sigmoidoscopy and FOBT. The detection rate for advanced neoplasia was three times higher following screening by sigmoidoscopy than by FOBT.


Subject(s)
Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/prevention & control , Mass Screening/methods , Occult Blood , Sigmoidoscopy , Colonic Polyps/diagnosis , Colonic Polyps/prevention & control , Colonoscopy , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Female , Humans , Italy , Male , Middle Aged , Odds Ratio , Patient Acceptance of Health Care , Postal Service/statistics & numerical data , Risk Factors , Sensitivity and Specificity , Surveys and Questionnaires
6.
Cancer ; 99(3): 129-34, 2003 Jun 25.
Article in English | MEDLINE | ID: mdl-12811852

ABSTRACT

BACKGROUND: The AutoPap 300 QC system (Tripath Imaging, Inc., Burlington, NC) is an automated device that was designed to screen conventionally prepared cervical smears and, more recently, thin-layer slide preparations. The system has been tested in large clinical trials. METHODS: A total of 14,145 cervical smears obtained from participants in the Florence screening program were eligible for the study. Smears were processed first with the AutoPap system and were classified into three different categories: 1) no further review (NFR), 2) review, and 3) process review (PR). Conventional manual reading was performed by 10 experienced cytopathologists. RESULTS: After AutoPap processing, 2398 smears were classified as NFR (16.9%), and 1818 smears were classified as PR (12.8%). Overall, there were 188 inadequate smears (1.3%) at conventional review and 125 inadequate smears (0.88%) at AutoPap review. Six-month repeat smears were prompted by 330 conventional reviews (2.3%) and by 222 AutoPap reviews (1.56%). Similarly, referral to colposcopy was prompted by 179 conventional reviews (1.2%) and by 147 AutoPap reviews (1.0%). Overall, 32 patients were diagnosed with high-grade cervical intraepithelial neoplasia as a result of assessment. Conventional reading detected 31 patients (28 patients were referred for colposcopy, and 3 patients were referred for repeat cytology), and the AutoPap system detected 30 patients (27 patients were referred for colposcopy, and 3 patients were referred for repeat cytology). CONCLUSIONS: The current experience suggested that conventional reading and AutoPap reading of cervical smears had essentially the same sensitivity, with slightly greater specificity for the AutoPap system. Thus, comparisons of the AutoPap system and conventional reading should focus mainly on cost analysis.


Subject(s)
Mass Screening/methods , Vaginal Smears/methods , Automation , Costs and Cost Analysis , Feasibility Studies , Female , Humans , Sensitivity and Specificity , Uterine Cervical Neoplasms/pathology , Vaginal Smears/economics , Vaginal Smears/instrumentation , Uterine Cervical Dysplasia/pathology
SELECTION OF CITATIONS
SEARCH DETAIL